Liren Tang
Directeur Général chez Welichem Biotech, Inc.
Postes actifs de Liren Tang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Welichem Biotech, Inc.
 Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Directeur Général | 18/11/2009 | - |
| President | 18/11/2009 | - | |
| Directeur Technique/Scientifique/R&D | 17/11/2009 | 18/11/2009 |
Historique de carrière de Liren Tang
Anciens postes connus de Liren Tang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Vancouver Coastal Health Research Institute
 Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Formation de Liren Tang
| University of British Columbia | Doctorate Degree |
Statistiques
Internationale
| Canada | 4 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Vancouver Coastal Health Research Institute
Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Bourse
- Insiders
- Liren Tang
- Expérience
